Hawk Ridge Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Blackbaud
BLKB
|
+$79.7M |
| 2 |
Bath & Body Works
BBWI
|
+$62.9M |
| 3 |
Sonos
SONO
|
+$49.7M |
| 4 |
Bio-Rad Laboratories Class A
BIO
|
+$49.2M |
| 5 |
Axalta
AXTA
|
+$43.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lamb Weston
LW
|
+$32.4M |
| 2 |
BWX Technologies
BWXT
|
+$29.1M |
| 3 |
Frontdoor
FTDR
|
+$23.6M |
| 4 |
Remitly
RELY
|
+$21.5M |
| 5 |
Enovis
ENOV
|
+$19.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.61% |
| 2 | Consumer Discretionary | 15.16% |
| 3 | Healthcare | 11.97% |
| 4 | Industrials | 11.46% |
| 5 | Materials | 10.64% |
Similar funds
Hawk Ridge Capital Management's Q3 2022 Portfolio in Review
As of Q3 2022, Hawk Ridge Capital Management held 62 positions worth $1.59B, up 10% from $1.44B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Hawk Ridge Capital Management deployed $324M of net new capital in Q3 2022, opening 12 new positions and adding to 17 existing holdings. Its largest new stake was Blackbaud: 1,479,265 shares worth $65.2M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Lamb Weston, an estimated $32.4M trimmed.
- Hawk Ridge Capital Management's largest Q3 2022 buy was Blackbaud: 1,479,265 shares worth $65.2M.
- Hawk Ridge Capital Management added most to Sonos in Q3 2022, an estimated $49.7M increase.
- Hawk Ridge Capital Management's biggest Q3 2022 reduction was Lamb Weston, cutting an estimated $32.4M.
- Hawk Ridge Capital Management fully exited Frontdoor in Q3 2022, selling an estimated $23.6M.
- Hawk Ridge Capital Management's ten largest holdings make up 43% of its $1.59B portfolio in Q3 2022.
- Hawk Ridge Capital Management opened 12 new positions and closed 12 in Q3 2022.
- Hawk Ridge Capital Management's portfolio value rose 10% quarter-over-quarter to $1.59B.
Based on Hawk Ridge Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.